Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...

Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

Some of the best possible returns for investors come by not going after megacaps, but instead pursuing stocks that have more ...

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Formycon AG is headquartered in Munich and is listed in the Prime Standard of the Frankfurt Stock Exchange: FYB / ISIN: DE000A1EWVY8 / WKN: A1EWVY and has been part of the selection index SDAX since ...

Ninety-six percent of online pharmacies were found to violate the law, meaning they were operating without a license and ...

These amendments represent the first significant changes to “healthy” labeling requirements in 30 years. In its new scheme, the FDA attempts to bring labeling requirements in line with 21st century ...

The government is changing what foods can be branded as “healthy.” It expects basically no one to listen.

The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...

The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.

On January 6, the US Food and Drug Administration (FDA) published in the Federal Register a notice announcing its ...